Media Experts
Drug discovery, targeted drug delivery, cancer
Philip Low
Download image
Philip S. Low, director of Purdue’s Center for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry, can speak about Purdue’sdrug discovery initiative and the pathway from scientific discovery to a therapeutic or technology available to a patient.
Low also can speak about his own work on the design and synthesis of technologies for targeted delivery of therapeutic and imaging agents to treat cancer, inflammatory and autoimmune diseases, and infectious diseases. He holds more than 45 U.S. patents, and eight drugs stemming from his research into targeting technologies are currently undergoing human clinical trials.
Contact: Philip Low, 765-494-5273, plow@purdue.edu
Professor Low’s related news releases:
- Purdue to accelerate drug discovery, development
- Purdue’s Low to participate in IBJ panel discussion on outlook for Indiana’s life sciences industry
- Purdue technology used in first fluorescence-guided ovarian cancer surgery
- Purdue takes prostate cancer treatment from concept to clinical trial
- Researcher lights the way to better drug delivery
- Purdue researchers develop technology to detect cancer by scanning surface veins
- Three Purdue professors elected as fellows of National Academy of Inventors
